Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Molecular Quality Controls is currently having emerging demand in the market owing to rising clinical laboratories, growing burden of different infectious diseases has led the requirement for molecular quality controls. The molecular quality control products ideally includes control and validation panel used to assist in the implementation and monitoring of assays for clinical laboratories, hospitals, ivd manufacturers among other to fulfill the requirement of consumer with precise results. The growing diseases and rising requirement for different molecular quality controls market products has accelerated the growth of market to huge extend.
The Europe market is driven by rising number of accredited clinical laboratories across the region has led the growing requirement for different molecular quality controls market products. The market provides provide the laboratories a confidence thereby the market has witnessed increasing need in accredited clinical laboratories. Furthermore, growing adoption of third-party quality controls provide independent assessment of testing or method for diseases testing. Likewise, rising demand for external quality assessment support is boosted the market to huge extend.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the Europe molecular quality controls market. In addition, complete analysis of changes on the Europe molecular quality controls market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 pandemic has provided a positive growth for market as number of laboratories were having increasing requirement molecular quality controls products.
The molecular quality controls market comprises of different market segment like product, analyte type, application, end users and country.
By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Instrument-specific Controls segment further includes PCR, DNA Sequencing & NGS and Other Technologies. Independent controls is anticipated to dominate in the market during the forecast period. The different benefits like cost saving, improved shelf life of products is expected to boost the demand for market during the estimated time period. Likewise, instrument-specific controls products like PCR, DNA Sequencing & NGS are expected to give rise in the Europe molecular quality controls market growth
The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls is likely to lead in the market due to rising application and demand for segment across the region as it helps in providing accuracy for monitoring assay performance, trouble shoot error thereby has witnessed increasing demand for market. Also, single-analyte controls is expected to witnessing increasing opportunities in upcoming years.
The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases is expected to gain major market share during estimated time period. The increasing burden of infectious diseases like Hepatitis, Tuberculosis among others has led the rising requirement for molecular quality controls products for precise results in laboratory testing. Additionally, oncology is expected to hold second position in the market as the region has rising cases of cancer due to lifestyle changes, environment among other factor has led the demand for market for diagnosis and screening with accuracy which is ultimately increasing demand for Europe molecular quality controls market.
The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories dominated the Europe molecular quality controls market in 2020 and is expected to witness the growth at fastest pace during the estimated time period. Growing application of molecular quality controls and usage of different assays, other products helps in improving the process of laboratory for accurate and early diseases diagnosis. In addition, hospitals, followed by ivd manufacturers & cros are expected to witness rapid growth in upcoming years. The rising patient’s inflow in hospital for diagnosis and treatment is contributing in the Europe molecular quality controls market growth.
The Europe molecular quality controls market is studied for the following countries like Germany, U.K, France, Italy, Spain and Rest of Europe. Germany leads in the Europe molecular quality controls market attributing to rising requirement for different market for infectious diseases diagnosis. Besides, changing healthcare dynamics and growing adoption of molecular quality controls has significantly boosted the growth of market. Furthermore, U.K is anticipated to hold second position owing to increasing demand and adoption for Third-Party Quality Controls. Likewise, France, followed by Italy among others are likely to contribute healthy growth in the market.
The key players in molecular quality controls market are Seracare Life Sciences Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Microbiologics Inc., Zeptometrix, Roche Diagnostics, Abbott Laboratories, Quidel, Qnostics and Maine Molecular Quality Controls Inc. among others.
March 2021: The Abbott Laboratories had announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) in one test. Alinity m uses Polymerase Chain Reaction (PCR) technology, which is known for its high sensitivity in detecting infectious diseases.
December 2020: Roche diagnostics had announced the launch of the cobas PIK3CA Mutation Test for patients with advanced or metastatic breast cancer. The cobas PIK3CA Mutation Test is a real-time PCR test for the qualitative detection and identification of 17 mutations in exons 2, 5, 8, 10, and 21 in the gene encoding the catalytic subunit of PIK3CA in DNA isolated from formalin-fixed paraffin-embedded tissue (FFPET).
May 2020: ZeptoMetrix had announced the development and release of a ready-to-use SARS-CoV-2 molecular quality control formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable
July 2018: Quidel had announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its Solana Bordetella Complete Assay, a molecular diagnostic assay to be used with the Solana molecular diagnostic instrument for the qualitative detection and differentiation of Bordetella pertussis and Bordetella parapertussis nucleic acids isolated from nasopharyngeal swab specimens obtained from patients suspected of having a respiratory tract infection.
The report analyses the Europe molecular quality controls market based on by product, analyte type, application, end users and country. By product, the molecular quality controls market includes key segment of independent controls, instrument-specific controls. Independent controls is anticipated to dominate in the market during the forecast period. The molecular quality controls market, includes different analyte type like single-analyte controls, multi-analyte controls. Multi-analyte controls is likely to lead in the market due to rising application and demand for segment across the region. The molecular quality controls market finds its major application in infectious diseases, oncology, genetic testing and others. Infectious diseases is expected to gain major market share during estimated time period. The molecular quality controls market has different end user like clinical laboratories, hospitals, ivd manufacturers & cros, academic and research institutes. Clinical laboratories dominated the Europe molecular quality controls market in 2020. The Europe molecular quality controls market is studied for the following countries like Germany, U.K, France, Italy, Spain and Rest of Europe.
Why to buy this report:
